Dermatology News

Monkeypox has recently been declared a public health emergency of international concern by the WHO, and more than 15,000 cases have been reported in the United States during the ongoing outbreak.

August has been designated as National Hair Loss Awareness Month in order to uplift the voices of those affected by hair loss and give them the opportunity to educate and connect with others.

A 5-year-old boy comes to your office with a painful left ear. The onset was 2 days earlier, with sudden, worsening pain and erythema of the pinna.

Guselkumab demonstrates sustained benefits for multiple, diverse manifestations of psoriatic arthritis through 1 year, according to data published in Rheumatology.

Dermatopathologists were often influenced by prior diagnoses when giving second opinions, especially in challenging cases, according to a study.

The FDA has approved a citrate-free, 100 mg/mL formulation of the Humira biosimilar Hadlima, according to a statement released by Samsung Bioepis and Organon.

The emergence of drugs inhibiting the JAK-STAT pathway has culminated in tyrosine kinase 2 inhibitors targeting psoriatic arthritis, lupus and other indications, noted a presenter at the 2022 Association of Women in Rheumatology conference.

The FDA has issued warnings to three companies for selling unapproved products to remove moles or skin tags, according to a press release.

A recent U.S. Supreme Court decision sending abortion rights back to the states could have serious implications for patients on isotretinoin and other dermatologic drugs.

The FDA has approved ustekinumab for the treatment of children aged 6 years and older with active psoriatic arthritis, according to a Janssen press release.